Sanofi (SAN:CA) Discusses Yr-Finish Late-Stage Pipeline Overview With Concentrate on Medical and Regulatory Developments December 16, 2025 11:15 AM EST
Firm Individuals
Thomas Larsen – Head of Investor Relations
Houman Ashrafian – Government VP & Head of Analysis Growth
Jean-Francois Toussaint – World Head of Analysis & Growth Vaccines – Sanofi Pasteur
Convention Name Individuals
Peter Verdult – BNP Paribas, Analysis Division
Luisa Hector – Joh. Berenberg, Gossler & Co. KG, Analysis Division
Richard Vosser – JPMorgan Chase & Co, Analysis Division
Sachin Jain – BofA Securities, Analysis Division
Simon Baker – Rothschild & Co Redburn, Analysis Division
James Quigley – Goldman Sachs Group, Inc., Analysis Division
Sarita Kapila – Morgan Stanley, Analysis Division
Graham Glyn Parry – Citigroup Inc., Analysis Division
Christopher LoBianco – TD Cowen, Analysis Division
Emmanuel Papadakis – Deutsche Financial institution AG, Analysis Division
Presentation
Thomas Larsen
Head of Investor Relations
Good afternoon and good morning, relying on the place you might be, and welcome to the Sanofi’s first year-end late-stage pipeline overview. I am Thomas Kudsk Larsen from the Investor Relations crew and I am happy to see so many individuals on the decision at present.
Earlier than we get began, I need to thank Alizé within the IR crew for main the work on at present’s name. I additionally need to remind everybody that our focus is on the medical and regulatory points of the mid- and late-stage pipeline. So we’ll intention at conserving any business or finance questions for an additional day. We would like science and endurance to take heart stage.
Throughout the name, we’ll spotlight crucial occasions in 2025 throughout our pipeline in immunology, uncommon illnesses, hemato-oncology, neurology and vaccines and supply the important thing information movement gadgets for the primary half and the second half of subsequent 12 months and 2027. As a result of a few 2025 information gadgets deflated expectations, we imagine that subsequent 12 months’s information movement comes with decrease anticipation basically. The presentation will
